IMMUNOTHERAPY

>

Latest News

FDA Approves New Subcutaneous Atezolizumab Formulation
FDA Approves New Subcutaneous Atezolizumab Formulation

September 12th 2024

The subcutaneous version of the cancer treatment atezolizumab is approved in all adult intravenous indications, including in lung, liver, and skin cancers.

SenoVax Investigational New Drug Application Filed With the FDA in NSCLC
SenoVax Investigational New Drug Application Filed With the FDA in NSCLC

July 26th 2024

FDA ODAC Votes Unanimously to Mandate Phase Assessments in NSCLC Perioperative Regimens
FDA ODAC Votes Unanimously to Mandate Phase Assessments in NSCLC Perioperative Regimens

July 25th 2024

Entrectinib Shows Durable Responses in ROS1-Positive NSCLC
Entrectinib Shows Durable Responses in ROS1-Positive NSCLC

July 23rd 2024

Immunotherapy for Angiosarcoma: Promising Results for Scalp and Face Tumors
Immunotherapy for Angiosarcoma: Promising Results for Scalp and Face Tumors

July 20th 2024

Latest CME Events & Activities

22nd Annual School of Breast Oncology

November 7-9, 2024

Register Now!

42nd Annual CFS: Innovative Cancer Therapy for Tomorrow®

November 13-15, 2024

Register Now!

Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

Community Oncology Connections™: Controversies and Conversations About HER2-Expressing Breast Cancer… Advances in Management from HER2-Low to Positive Disease

View More

Emerging Treatments and Evolving Paradigms in HER2-Low Breast Cancer

View More

Matching the Right Patients to the Right Therapies in TNBC: Case-Based Applications of Immune Checkpoint Inhibitors, PARP Inhibitors, and TROP2-Targeted ADCs

View More

Matching the Right Patients to the Right Therapies in TNBC: Case-Based Applications of Immune Checkpoint Inhibitors, PARP Inhibitors, and TROP2-Targeted ADCs

View More

Clinical Vignettes™: The Experts Explain How They Integrate PET Imaging into Metastatic HR+ Breast Cancer Care Settings

View More

School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio

View More

Annual Hawaii Cancer Conference

January 25-26, 2025

Register Now!

41st Annual CFS®: Innovative Cancer Therapy for Tomorrow

View More

42nd Annual Miami Breast Cancer Conference®

March 6 - 9, 2025

Register Now!

The Evolving Tool Box in Advanced HR+/HER2– Breast Cancer: What You Need to Know About Next-Generation SERDs, PI3K/AKT, ADCs, CDK4/6 and Beyond…

View More

Next-Generation Endocrine Therapy for ER+/HER2- Breast Cancer: Addressing Unmet Needs and Keys to Optimization in Clinical Practice

View More

Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions

View More

Empowering Breast Cancer Patients with Non-Opioid Pain Management Innovations

View More

Leveraging Multidisciplinary Teams in an Evolving Treatment Landscape for Early- Stage HR+, HER2- Breast Cancer

View More

Coffee Talk™: Navigating the Impact of HER2/3, TROP2, and PARP from Early Stage to Advanced Breast Cancer Care

View More

Community Practice Connection™: Leveraging Multidisciplinary Teams in an Evolving Treatment Landscape for Early- Stage HR+, HER2- Breast Cancer

View More

How We Do It™: Defining HER2 Low on Your Pathology Reports to Make Informed Decisions in Breast Cancer Treatment

View More

Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®

View More

Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

View More

24th Annual International Congress on the Future of Breast Cancer® West

July 18-19, 2025

Register Now!

24th Annual International Congress on the Future of Breast Cancer® East

July 11-12, 2025

Register Now!

Differentiating Adverse Events for Antibody-Drug Conjugates Across Solid Tumor Management

View More

Community Practice Connections™: 23rd Annual International Congress on the Future of Breast Cancer West

View More

School of Breast Oncology® (SOBO) Slide & Lecture Library

Joyce O’Shaughnessy, MD

View More

More News